|Date: 25 July (Thursday) 14:00 – 18:00
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
Cross Border Investments
With the initial public offering (IPO) becoming just one of many available funding and jumpstart options for a biomed company, M&A meanwhile creates growth while encouraging financial efficiency. Technology giants with their deep pockets meanwhile are increasingly using M&A to gain a foothold in healthcare. In the session we’ll hear from experts in M&A and growth with lessons for biomed entities and beyond.